Literature DB >> 26225001

Bisphosphonate Related Osteonecrosis of the Jaw: An Update.

Vijay Kumar1, Raman Kant Sinha2.   

Abstract

OBJECTIVES: The aim of this paper is to summarize different diagnostic criteria as well as probable aetiopathogenesis of bisphosphonates related osteonecrosis of the jaw.
MATERIALS AND METHODS: The electronic search of peer-reviewed journals were performed in MEDLINE (PubMed) database in order to find the relevant articles on bisphosphonates related osteonecrosis of the jaw (BP-related ONJ). The search was restricted to English language articles, published from January 2002 to May 2013. On the basis of these articles, probable aetiopathogenesis and different diagnostic criteria of BP-related ONJ were summarized.
RESULTS: BP-related ONJ is related to the development of avascular necrosis or dead jaw bones. In recent literature many given hypotheses show the aetiopathogenesis and diagnosis of BP-related ONJ which are interlinked and have multifactorial nature. Their diagnosis revolves around four main diagnostic criteria that differentiate it from other conditions which can delay bone healing.
CONCLUSIONS: Factors like potency of bisphosphonates, biology of jaw bone, antiangiogenic property of bisphosphonates and soft tissue toxicity in combination with present infection, other drugs, pre-existing pathologies, compromised immune response and dentoalveolar trauma may lead to development of BP-related ONJ.

Entities:  

Keywords:  Bisphosphonate osteonecrosis; Bisphosphonate-related osteonecrosis of the jaws; Bisphosphonates

Year:  2013        PMID: 26225001      PMCID: PMC4518805          DOI: 10.1007/s12663-013-0564-x

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  62 in total

1.  Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

Authors:  M Ardine; D Generali; M Donadio; S Bonardi; M Scoletta; A M Vandone; M Mozzati; O Bertetto; A Bottini; L Dogliotti; A Berruti
Journal:  Ann Oncol       Date:  2006-03-08       Impact factor: 32.976

Review 2.  Osteonecrosis of the jaw: who gets it, and why?

Authors:  Ian R Reid
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

3.  Bisphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy.

Authors:  Mustafa Erkan; Oğuz Bilgi; Mesut Mutluoğlu; Günalp Uzun
Journal:  JOP       Date:  2009-09-04

4.  Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Achim Weber; C James Kirkpatrick
Journal:  J Oral Pathol Med       Date:  2006-03       Impact factor: 4.253

5.  Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge.

Authors:  Michael R Markiewicz; Joseph E Margarone; John H Campbell; Alfredo Aguirre
Journal:  J Am Dent Assoc       Date:  2005-12       Impact factor: 3.634

6.  Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.

Authors:  Matthew S Epstein; Fredrick W Wicknick; Joel B Epstein; James R Berenson; Meir Gorsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-11

7.  Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: a comparative study.

Authors:  Jose V Bagan; Yolanda Jiménez; Sergio Hernández; Judith Murillo; Jose M Díaz; Rafael Poveda; Enrique Carbonell; Jose M Sanchis; Carmen Gavaldá; Crispian Scully
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2009-12-01

8.  Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.

Authors:  Pedro Infante Cossío; Antonio Cabezas Macián; José Luis Pérez Ceballos; Julián Palomino Nicas; José Luis Gutiérrez Pérez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2008-01-01

9.  Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw.

Authors:  Marco Cicciù; Alan Scott Herford; Gintaras Juodžbalys; Enrico Stoffella
Journal:  J Craniofac Surg       Date:  2012-05       Impact factor: 1.046

10.  Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies.

Authors:  Falk Wehrhan; Peter Hyckel; Arndt Guentsch; Emeka Nkenke; Phillip Stockmann; Karl A Schlegel; Friedrich W Neukam; Kerstin Amann
Journal:  J Transl Med       Date:  2011-07-04       Impact factor: 5.531

View more
  5 in total

1.  Bisphosphonate-related osteonecrosis of jaws in advanced stage breast cancer was detected from bone scan: a case report.

Authors:  Prakasit Chirappapha; Saowanee Kitudomrat; Thanaporn Thongjood; Rangsima Aroonroch
Journal:  Gland Surg       Date:  2017-02

2.  In vitro Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.

Authors:  Krit Rattanawonsakul; George Bullock; Robert Bolt; Frederik Claeyssens; Simon Atkins; Vanessa Hearnden
Journal:  Front Oral Health       Date:  2022-06-20

3.  Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Siri Paulo; Mafalda Laranjo; Ana M Abrantes; João Casalta-Lopes; Kathleen Santos; Ana C Gonçalves; Anabela Baptista Paula; Carlos Miguel Marto; Ana Bela Sarmento-Ribeiro; Eunice Carrilho; Arménio Serra; Maria F Botelho; Manuel M Ferreira
Journal:  Materials (Basel)       Date:  2019-06-06       Impact factor: 3.623

4.  Evaluation of a collagen matrix in a mandible defect in rats submitted to the use of bisphosphonates.

Authors:  Vanessa Vasconcelos Cunha; Paulo Goberlânio de Barros Silva; José Vitor Mota Lemos; Joyce Ohana Lima Martins; Milena Oliveira Freitas; Rafael Linard Avelar
Journal:  Acta Cir Bras       Date:  2020-11-30       Impact factor: 1.388

5.  Determination of bisphosphonates anti-resorptive properties based on three forms of ceramic materials: Sorption and release process evaluation.

Authors:  Monika Zielińska; Ewa Chmielewska; Tomasz Buchwald; Adam Voelkel; Paweł Kafarski
Journal:  J Pharm Anal       Date:  2020-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.